Inhibition by KF17837 of adenosine A2A receptor‐mediated modulation of striatal GABA and ACh release
Open Access
- 1 September 1994
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 113 (1) , 43-48
- https://doi.org/10.1111/j.1476-5381.1994.tb16171.x
Abstract
The effect of the A2A adenosine receptor agonist, 2‐p‐(‐2‐carboxyethyl)phenethyl‐amino‐5′‐N‐ethylcarboxamidoadenosine (CGS 21680) on the potassium evoked release of [3H]‐γ‐aminobutyric acid ([3H]‐GABA) from nerve terminals derived from the caudate‐putamen and the globus pallidus of the rat was compared. In both preparations CGS 21680 (1 nm) inhibited the [3H]‐GABA release evoked by 15 mm KCl but had no effect on that evoked by 30 mm KCl. The ability of CGS 21680 (1 nm) to inhibit the release of [3H]‐GABA from striatal nerve terminals was unaffected by the presence of the GABA receptor antagonists, bicuculline (10 μm), phaclofen (100 μm) and 2‐hydroxysaclofen (100 μm). Similarly the opioid receptor antagonist, naloxone (10 μm), the adenosine A1 receptor antagonist, 8‐cyclopentyl‐1,3‐dipropylxanthine (DPCPX, 40 nm), and the cholinoceptor antagonists, mecamylamine (10 μm) and atropine (100 nm) had no effect on this inhibition. The ability of CGS 21680 (0.1 nm) to stimulate the release of [3H]‐acetylcholine ([3H]‐ACh) from striatal nerve terminals was unaffected by the presence of bicuculline (10 μm), 2‐hydroxysaclofen (100 μm), phaclofen (100 μm), naloxone (10 μm) and DPCPX (4 nM). The novel A2A receptor antagonist, (E)‐8‐(3,4‐dimethoxystyryl)‐1,3‐dipropyl‐7‐methylxanthine (KF 17837), blocked the CGS 21680 (1 nm)‐induced inhibition of [3H]‐GABA efflux with an EC50 of approximately 30 nm and also antagonized the CGS 21680 (0.1 nm)‐induced stimulation of [3H]‐ACh release with an EC50 of approximately 0.3 nm. It is concluded that the A2A adenosine receptor is present on both GABAergic and cholinergic nerve terminals of the rat striatum and that in both the caudate‐putamen and the globus pallidus this receptor inhibits [3H]‐GABA release. No evidence was seen for a difference in the ligand binding sites of this receptor in the two groups of nerve terminals.Keywords
This publication has 31 references indexed in Scilit:
- KF17837 ((E)-8-(3,4-dimethoxystyryl)-1,3-dipropyl-7-methylxanthine) a potent and selective adenosine A2 receptor antagonistEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- The binding of the adenosine A2 receptor selective agonist [3H]CGS 21680 to rat cortex differs from its binding to rat striatumEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- The subcellular distribution of [3H]-CGS 21680 binding sites in the rat striatum: Copurification with cholinergic nerve terminalsNeurochemistry International, 1993
- Opposing actions of an adenosine A2 receptor agonist and a GTP analogue on the regulation of dopamine D2 receptors in rat neostriatal membranesEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Evidence for the presence of excitatory A2 adenosine receptors in the rat hippocampusNeuroscience Letters, 1992
- Stimulation of adenosine A2 receptors induces catalepsyNeuroscience Letters, 1991
- Subtypes of adenosine receptors in the brainstem mediate opposite blood pressure responsesNeuropharmacology, 1991
- RDC8 codes for an adenosine A2 receptor with physiological constitutive activityBiochemical and Biophysical Research Communications, 1990
- Distinct Muscarinic Receptor Subtypes Differentially Modulate Acetylcholine Release from Corticocerebral SynaptosomesJournal of Neurochemistry, 1990
- Ca2+-Dependent Regulation of Presynaptic Stimulus-Secretion CouplingJournal of Neurochemistry, 1989